Teva Pharmaceutical Industries Ltd (TEVA) is down Thursday morning, with the stock declining -1.44% in pre-market trading to 9.55. TEVA's short-term technical score of 57 indicates that the stock has traded more bullishly over the last month than 57% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 125 out of 146 industries, the stock ranks higher than 74% of stocks. Teva Pharmaceutical Industries Ltd has risen 13.33% over the past month, closing at $8.78 on November 2. During this period of time, the stock fell as low as $8.68 and as high as $10.07. TEVA has an average analyst recommendation of Buy. The company has an average price target of $11.00.
TEVA has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on TEVA!